SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000078003-20-000056
Filing Date
2020-07-28
Accepted
2020-07-28 08:28:12
Documents
18
Period of Report
2020-07-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pfe-6282020x8kcoverpage.htm   iXBRL 8-K 57743
2 EXHIBIT 99 pfe-06282020xex99.htm EX-99 2614842
8 oldpfelogowhite.jpg GRAPHIC 95575
9 pfizerlogo2019.jpg GRAPHIC 15668
10 upjohnlogo.jpg GRAPHIC 230605
  Complete submission text file 0000078003-20-000056.txt   3451543

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20200728.xsd EX-101.SCH 4941
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pfe-20200728_cal.xml EX-101.CAL 615
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20200728_def.xml EX-101.DEF 15636
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20200728_lab.xml EX-101.LAB 34372
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20200728_pre.xml EX-101.PRE 17552
11 EXTRACTED XBRL INSTANCE DOCUMENT pfe-6282020x8kcoverpage_htm.xml XML 7344
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 201051832
SIC: 2834 Pharmaceutical Preparations